Weis Markets Inc: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 10, 2023 and accepted by EDGAR at Aug 10, 2023, 13:32 ET.
Market risk
As filed, 762 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Quantitative Disclosure - There have been no material changes in the Company’s market risk during the fiscal quarter ended July 1, 2023. Quantitative information is set forth in Item 7a on the Company’s Annual Report on Form 10-K under the caption “Quantitative and Qualitative Disclosures About Market Risk,” which was filed for the fiscal year ended December 31, 2022, and is incorporated herein by reference.
Qualitative Disclosure - This information is set forth in the Company’s Annual Report on Form 10-K under the caption “Liquidity and Capital Resources,” within “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which was filed for the fiscal year ended December 31, 2022, and is incorporated herein by reference.
Controls and procedures
As filed, 1,340 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Chief Executive Officer and the Chief Financial Officer, together with the Company’s Disclosure Committee, evaluated the Company’s disclosure controls and procedures as of the fiscal quarter ended July 1, 2023. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report to ensure that information required to be disclosed by the Company in the reports filed or submitted by it under the Securities Exchange Act of 1934, as amended, was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports was accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
In connection with the evaluation described above, there was no change in the Company’s internal control over financial reporting during the fiscal quarter ended July 1, 2023, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $1.18bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $2.32bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $299.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-01 | $584.8m | us-gaap:GrossProfit |
| Operating income | 3 months2023-04-02 to 2023-07-01 | $45.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-01 | $78.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $13.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $22.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | $34.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | $60.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | $1.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | $2.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | $1.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | $2.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 26,898,443 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 26,898,443 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | $80.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-01 | $49.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-01-01 to 2023-07-01 | $18.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-07-01 | $139.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $765.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $1.97bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $317.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $628.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-01 | $1.35bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000105418-23-000033. Last ingested by Listed: Nov 5, 2026, 13:02 ET. Listed shows no prices and gives no investment advice.